Home / Companies / KAKUSHIME MATSUDA SUISAN

KAKUSHIME MATSUDA SUISAN FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

KAKUSHIME MATSUDA SUISAN has 0 FDA recalls, 1 inspection, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to KAKUSHIME MATSUDA SUISAN, the most recent on Sep 18, 2019.

What these totals cover: FDA records filed under the name "KAKUSHIME MATSUDA SUISAN".

Latest inspection: Jul 9, 2019 · OAI

Summary

Record counts and when each FDA source was last refreshed
Records	Count	Last refreshed	Source as of	Status
Recalls	0	Nov 8, 2026	File dated Nov 3, 2026	Current
510(k) clearances	0	Nov 8, 2026	File dated Nov 2, 2026	Current
Inspections	1	Nov 14, 2026	Newest record Nov 5, 2026	Current
Compliance actions	1	Nov 2, 2026	Newest record Oct 29, 2026	Current

Reviewing KAKUSHIME MATSUDA SUISAN as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check KAKUSHIME MATSUDA SUISAN yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

KAKUSHIME MATSUDA SUISAN FDA Warning Letters

1 warning letter on Sep 18, 2019.

Issued	Subject	Issuing office	Close-out letter
Sep 18, 2019

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent FDA inspections

1 inspection on Jul 9, 2019.

Date	Site	Product	Classification	FEI
Jul 9, 2019	Hakodate, Japan	Food/Cosmetics	Official Action Indicated (OAI)	3010808608

NAI: No objectionable conditions or practices were found during the inspection.
VAI: Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI: Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under KAKUSHIME MATSUDA SUISAN: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Sep 18, 2019.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

Facility	Location	Inspections	Latest
FEI 3010808608	Hakodate, Japan	1	Jul 9, 2019

KAKUSHIME MATSUDA SUISAN and the FDA: common questions

Has KAKUSHIME MATSUDA SUISAN received an FDA warning letter?

Yes. FDA has issued 1 warning letter to KAKUSHIME MATSUDA SUISAN. The most recent is dated Sep 18, 2019.

Has KAKUSHIME MATSUDA SUISAN received an FDA Form 483?

FDA has not published a Form 483 for "KAKUSHIME MATSUDA SUISAN" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect KAKUSHIME MATSUDA SUISAN?

The most recent FDA inspection on file ended Jul 9, 2019 at Hakodate, Japan and was classified OAI. FDA has 1 inspection of KAKUSHIME MATSUDA SUISAN on file, 1 of them classified OAI (official action indicated).

Need more than this page shows? Ask about KAKUSHIME MATSUDA SUISAN in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.